---
title: "DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres in unresectable HCC"
date: "2025-09-23T15:22:08.000Z"
publishedDate: "23 septembre 2025"
summary: "An interim analysis of the DOORwaY90 clinical trial has shown that yttrium-90 (Y-90) resin microspheres—SIR-Spheres (Sirtex)—using partition dosimetry, achieved high objective response rates and durable tumour control in patients with unresectable and unablatable hepatocellular carcinoma (HCC). Presenting the results at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual congress (13–17 September, Barcelona, Spain), principal [&#8230;] The post DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres in unresectable HCC appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/doorway90-clinical-trial-interim-analysis-demonstrates-efficacy-of-y-90-resin-microspheres-in-unresectable-hcc/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-09-23-doorway90-clinical-trial-interim-analysis-demonstrates-efficacy-of-y-90-resin-microspheres-in-unresectable-hcc"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2025/09/Image-46-scaled.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/doorway90-clinical-trial-interim-analysis-demonstrates-efficacy-of-y-90-resin-microspheres-in-unresectable-hcc/"
---

![DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres in unresectable HCC](http://interventionalnews.com/wp-content/uploads/sites/13/2025/09/Image-46-scaled.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/doorway90-clinical-trial-interim-analysis-demonstrates-efficacy-of-y-90-resin-microspheres-in-unresectable-hcc/*

## L’essentiel

An interim analysis of the DOORwaY90 clinical trial has shown that yttrium-90 (Y-90) resin microspheres—SIR-Spheres (Sirtex)—using partition dosimetry, achieved high objective response rates and durable tumour control in patients with unresectable and unablatable hepatocellular carcinoma (HCC). Presenting the results at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual congress (13–17 September, Barcelona, Spain), principal [&#8230;] The post DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres in unresectable HCC appeared first on Interventional News .

## Lien source

https://interventionalnews.com/doorway90-clinical-trial-interim-analysis-demonstrates-efficacy-of-y-90-resin-microspheres-in-unresectable-hcc/
